Literature DB >> 1906693

Fulminant hepatic failure associated with 2',3'-dideoxyinosine (ddI).

K K Lai1, D L Gang, J K Zawacki, T P Cooley.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1906693     DOI: 10.7326/0003-4819-115-4-283

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  21 in total

Review 1.  Mechanisms of alcohol-mediated hepatotoxicity in human-immunodeficiency-virus-infected patients.

Authors:  Gyongyi Szabo; Samir Zakhari
Journal:  World J Gastroenterol       Date:  2011-05-28       Impact factor: 5.742

Review 2.  Antiretroviral therapy: reverse transcriptase inhibition.

Authors:  K J Connolly; S M Hammer
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

3.  Nodular regenerative hyperplasia of the liver associated with didanosine persists for years even after its interruption.

Authors:  Daniel Hofmaenner; Helen Kovari; Achim Weber; Dominik Weishaupt; Roberto F Speck
Journal:  BMJ Case Rep       Date:  2011-05-03

Review 4.  Mitochondrial injury. Lessons from the fialuridine trial.

Authors:  P Honkoop; H R Scholte; R A de Man; S W Schalm
Journal:  Drug Saf       Date:  1997-07       Impact factor: 5.606

5.  Acute hepatic failure and lactate acidosis associated with antiretroviral treatment for HIV.

Authors:  Robert O Koch; Ivo W Graziadei; Robert Zangerle; Nikolaus Romani; Hans Maier; Wolfgang Vogel
Journal:  Wien Klin Wochenschr       Date:  2003-02-28       Impact factor: 1.704

Review 6.  Treatment of HIV infection. Tolerability of commonly used antiretroviral agents.

Authors:  D W Notermans; R van Leeuwen; J M Lange
Journal:  Drug Saf       Date:  1996-09       Impact factor: 5.606

Review 7.  Targeting hepatitis B therapy to the liver. Clinical pharmacokinetic considerations.

Authors:  P C Rensen; R L de Vrueh; T J van Berkel
Journal:  Clin Pharmacokinet       Date:  1996-08       Impact factor: 6.447

Review 8.  Adverse effects of antiretroviral therapy for HIV infection.

Authors:  Valentina Montessori; Natasha Press; Marianne Harris; Linda Akagi; Julio S G Montaner
Journal:  CMAJ       Date:  2004-01-20       Impact factor: 8.262

Review 9.  A review of the toxicity of HIV medications.

Authors:  Asa M Margolis; Harry Heverling; Paul A Pham; Andrew Stolbach
Journal:  J Med Toxicol       Date:  2014-03

Review 10.  Didanosine. A review of its antiviral activity, pharmacokinetic properties and therapeutic potential in human immunodeficiency virus infection.

Authors:  D Faulds; R N Brogden
Journal:  Drugs       Date:  1992-07       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.